IBC Life Sciences Presents 4 Conferences * 1 Exhibition
Empowered Antibody TherapiesCancer Genomics & Cancer Mutations
Next Generation Sequencing & Genomic Medicine <em>Applications Summit</em>Cancer Stem Cells & the Tumor Microenvironment
Drug Discovery & Development Week

Registration

Online Registration is closed.
Read more details on how to register.

Sponsors

  • Gold Sponsor

    Roche Applied Science

  • Bronze Sponsors

    Agilent Technologies

  • Baxter

Cancer Genomics & Cancer Mutations

Cancer Genomics & Cancer Mutations

Alternate Language Options:
  • South Korea
  • China
  • Taiwan
  • Recommend to a Friend
  • LinkedIn
  • News Feeds

Event Information

August 02 - 04, 2010 · Hyatt Regency San Francisco Airport · Burlingame, CA

Document Title

Conference Overview

Attendee Onsite/Conference Information

Conference Overview

Hear leading cancer researches and drug developers share their latest results on:

  • Mutational studies in testicular tumors and lung cancer
  • Personalized clinical diagnostics in colorectal cancer
  • Systems approaches for molecularly targeted agents
  • Sequencing of tumors versus matched normal
  • Integrating genomic biomarkers into clinical trials
  • Translating the cancer genome into personalized cancer care

This conference will provide you with new approaches for targeting cancers and personalizing treatment regimens in order to dramatically improve cancer treatment at the bedside.

»Conference Agenda
»List of Speakers

Why Attend?

Ground-breaking cancer genetics research and technological advances are leading to a better understanding of cancer biology, cancer mutations and new approaches to drug and diagnostic development.

Attendees of this conference will hear from these world-renowned cancer researchers and drug developers who will discuss data from their latest projects:

  • Andrew Fire, Ph.D., Stanford University School of Medicine
  • Elaine R. Mardis, Ph.D., Washington University
  • Lynda Chin, M.D., Dana-Farber
  • David Cox, M.D., Ph.D., Pfizer, Inc.
  • David C. Heimbrook, Ph.D., Roch

Who Attends?

Chief Scientific Officers, Vice Presidents, Directors, Managers, Heads of Departments, Group/Team/Project Leaders, Scientists, Investigators and Researchers working in the following areas:

  • Oncology R&D
  • Cancer Biology
  • Hematology
  • Drug Discovery R&D
  • Lead Discovery
  • Genetics
  • Pharmacogenomics
  • Biomarkers
  • Translational Research
  • Clinical Science/R&D
  • Drug Delivery
  • Antibody Discovery
  • Protein Sciences
  • Exploratory Clinical Development
  • Medical Sciences

»See who is already registered to attend

Receive Complimentary MedTRACK access when you register for Drug Discovery and Development Week.

MedTrack

Life Science Analytics and IBC Life Sciences are teaming up to provide complimentary MedTRACK access for attendees of the Drug Discovery and Development Week.

MedTRACK helps track competitors, find partners, identify new markets, and aid in conference and meeting preparation.

MedTRACK provides a centralized resource for company, product, deal, patent, and epidemiology information.

Registered attendees will receive an e-mail regarding the registration process one week prior to the start of the complimentary access, which is valid from July 26th through August 9th. This is an incredible value - so don't miss it!